OTCMKTS:PMCUF

Pro Medicus Competitors

$35.65
0.00 (0.00 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$35.65
Now: $35.65
$35.65
50-Day Range
$32.83
MA: $33.82
$36.34
52-Week Range
$15.00
Now: $35.65
$37.48
VolumeN/A
Average Volume1,263 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Pro Medicus (OTCMKTS:PMCUF) Vs. BNVIF, CNONF, DOCRF, EVAHF, EWLL, and FORA

Should you be buying PMCUF stock or one of its competitors? Companies in the industry of "health information services" are considered alternatives and competitors to Pro Medicus, including Binovi Technologies (BNVIF), CannaOne Technologies (CNONF), CloudMD Software & Services (DOCRF), EGF Theramed Health (EVAHF), eWellness Healthcare (EWLL), and Forian (FORA).

Pro Medicus (OTCMKTS:PMCUF) and Binovi Technologies (OTCMKTS:BNVIF) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation and earnings.

Valuation and Earnings

This table compares Pro Medicus and Binovi Technologies' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pro MedicusN/AN/AN/AN/AN/A
Binovi TechnologiesN/AN/AN/AN/AN/A

Profitability

This table compares Pro Medicus and Binovi Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Pro MedicusN/AN/AN/A
Binovi TechnologiesN/AN/AN/A

Analyst Ratings

This is a breakdown of current recommendations and price targets for Pro Medicus and Binovi Technologies, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pro Medicus01202.67
Binovi Technologies0000N/A

Summary

Pro Medicus beats Binovi Technologies on 1 of the 1 factors compared between the two stocks.

Pro Medicus (OTCMKTS:PMCUF) and CannaOne Technologies (OTCMKTS:CNONF) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, profitability, earnings, analyst recommendations and risk.

Earnings & Valuation

This table compares Pro Medicus and CannaOne Technologies' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pro MedicusN/AN/AN/AN/AN/A
CannaOne TechnologiesN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of current recommendations for Pro Medicus and CannaOne Technologies, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pro Medicus01202.67
CannaOne Technologies0000N/A

Profitability

This table compares Pro Medicus and CannaOne Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Pro MedicusN/AN/AN/A
CannaOne TechnologiesN/AN/AN/A

Summary

Pro Medicus beats CannaOne Technologies on 1 of the 1 factors compared between the two stocks.

CloudMD Software & Services (OTCMKTS:DOCRF) and Pro Medicus (OTCMKTS:PMCUF) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation.

Analyst Recommendations

This is a summary of recent ratings and price targets for CloudMD Software & Services and Pro Medicus, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CloudMD Software & Services00203.00
Pro Medicus01202.67

CloudMD Software & Services currently has a consensus price target of $3.3750, indicating a potential upside of 110.28%. Given CloudMD Software & Services' stronger consensus rating and higher possible upside, equities research analysts plainly believe CloudMD Software & Services is more favorable than Pro Medicus.

Earnings and Valuation

This table compares CloudMD Software & Services and Pro Medicus' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CloudMD Software & ServicesN/AN/AN/AN/AN/A
Pro MedicusN/AN/AN/AN/AN/A

Profitability

This table compares CloudMD Software & Services and Pro Medicus' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CloudMD Software & ServicesN/AN/AN/A
Pro MedicusN/AN/AN/A

Summary

CloudMD Software & Services beats Pro Medicus on 2 of the 2 factors compared between the two stocks.

Pro Medicus (OTCMKTS:PMCUF) and EGF Theramed Health (OTCMKTS:EVAHF) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Pro Medicus and EGF Theramed Health, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pro Medicus01202.67
EGF Theramed Health0000N/A

Valuation & Earnings

This table compares Pro Medicus and EGF Theramed Health's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pro MedicusN/AN/AN/AN/AN/A
EGF Theramed HealthN/AN/AN/AN/AN/A

Profitability

This table compares Pro Medicus and EGF Theramed Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Pro MedicusN/AN/AN/A
EGF Theramed HealthN/AN/AN/A

Summary

Pro Medicus beats EGF Theramed Health on 1 of the 1 factors compared between the two stocks.

Pro Medicus (OTCMKTS:PMCUF) and eWellness Healthcare (OTCMKTS:EWLL) are both computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings and risk.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Pro Medicus and eWellness Healthcare, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pro Medicus01202.67
eWellness Healthcare0000N/A

Profitability

This table compares Pro Medicus and eWellness Healthcare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Pro MedicusN/AN/AN/A
eWellness HealthcareN/AN/AN/A

Valuation and Earnings

This table compares Pro Medicus and eWellness Healthcare's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pro MedicusN/AN/AN/AN/AN/A
eWellness HealthcareN/AN/AN/AN/AN/A

Summary

Pro Medicus beats eWellness Healthcare on 1 of the 1 factors compared between the two stocks.

Pro Medicus (OTCMKTS:PMCUF) and Forian (NASDAQ:FORA) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

Earnings and Valuation

This table compares Pro Medicus and Forian's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pro MedicusN/AN/AN/AN/AN/A
ForianN/AN/AN/AN/AN/A

Profitability

This table compares Pro Medicus and Forian's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Pro MedicusN/AN/AN/A
ForianN/AN/AN/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Pro Medicus and Forian, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pro Medicus01202.67
Forian0000N/A

Summary

Pro Medicus beats Forian on 1 of the 1 factors compared between the two stocks.


Pro Medicus Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Binovi Technologies logo
BNVIF
Binovi Technologies
0.0$0.06flat$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Down
CannaOne Technologies logo
CNONF
CannaOne Technologies
0.6$1.01flat$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Up
CloudMD Software & Services logo
DOCRF
CloudMD Software & Services
1.7$1.61flat$0.00N/A0.00Decrease in Short Interest
News Coverage
EGF Theramed Health logo
EVAHF
EGF Theramed Health
0.0$0.11flat$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Down
EWLL
eWellness Healthcare
0.6$0.00flat$0.00N/A0.00Gap Up
FORA
Forian
0.3$12.05flat$0.00N/A0.00
M3 logo
MTHRF
M3
1.0$76.00flat$0.00N/A0.00
NEWUF
Newtopia
1.7$0.41flat$0.00N/A0.00
PANHF
Ping An Healthcare and Technology
1.0$12.20flat$0.00N/A0.00
CBIIF
Skylight Health Group
0.0$0.92flat$0.00N/A0.00High Trading Volume
News Coverage
Gap Down
UCBB
US-China Biomedical Technology
0.3$0.13flat$0.00N/A0.00
WELL Health Technologies logo
WLYYF
WELL Health Technologies
1.6$5.88flat$0.00N/A0.00
This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.